Siemens Charts a New Course Amid Record Orders and Strategic Overhaul

Siemens raises guidance on record 120B euro backlog, spins off Healthineers, and invests 200M in AI factory, despite share price weakness.

Siemens AG is accelerating a profound corporate transformation, even as its operational performance reaches new heights. The German industrial giant finds itself at a crossroads, navigating a complex blend of strategic divestment, aggressive investment in artificial intelligence, and substantial share buybacks, all against a backdrop of record-breaking order books and surprising stock market weakness.

Operational Momentum and Revised Guidance

The company's core business is demonstrating remarkable strength. For the first quarter of its 2026 fiscal year, Siemens reported an unprecedented order backlog of 120 billion euros. A significant growth driver has been its data center business, where revenue surged by 35%, propelled by robust demand for cloud infrastructure, particularly in the United States.

This powerful operational dynamic prompted management to raise its full-year outlook. The forecast for adjusted earnings per share was increased to a range of 10.70 to 11.10 euros.

A Strategic Pivot: Unwinding the Healthineers Stake

Central to Siemens' long-term strategy is a radical reshaping of its corporate portfolio. Management is advancing plans to reduce its majority stake in the medical technology subsidiary, Siemens Healthineers. The proposed method involves a direct spin-off of approximately 30% of Healthineers shares to existing Siemens shareholders.

This move is designed to sharpen the strategic focus of the core Siemens entity. If executed, Healthineers would eventually be carried on the books as a pure financial investment, marking a decisive step away from the conglomerate's older structures.

Investing in the Future: The AI Factory and NVIDIA Partnership

Parallel to this divestment, Siemens is making substantial capital commitments to secure its future competitiveness. The company is investing 200 million euros to establish a new "AI factory" at its facility in Amberg. The ambitious goal is to create an autonomous, AI-driven production environment by 2030.

This investment underscores a key strategic partnership with US chipmaker NVIDIA. The collaboration is focused on developing advanced industrial AI solutions, embedding next-generation technology directly into Siemens' manufacturing ecosystem.

Market Disconnect: Share Price Lags Fundamentals

Despite the strong operational and strategic news, Siemens' share price has failed to reflect this positive momentum. Since the start of the year, the equity has lost over 6% of its value. Recently, the stock price declined below the closely watched 200-day moving average, a key technical level situated around 235 euros.

In response to this discrepancy between fundamental strength and technical weakness, the company has accelerated its share repurchase program. Siemens has already deployed 4.4 billion euros into buybacks, with plans to retire a further 18 million of its own shares in March. This action is intended to provide arithmetic support for earnings per share.

The Road Ahead: Key Dates for Investors

The coming months are likely to be critical for investor sentiment. The market is awaiting concrete details and a definitive timeline for the Healthineers transaction, which is scheduled to be announced at the start of the second quarter. Subsequently, on May 13, 2026, the company will release its second-quarter results.

These figures will be scrutinized to determine whether the ongoing boom in data center revenue can continue to more than offset the costs associated with the group's extensive transformation. Investors are left to weigh the promise of a streamlined, AI-powered industrial leader against the near-term complexities of a corporate metamorphosis.